Avantor, Inc. Overview
Industry: Specialty Chemicals
Sector: Basic Materials
Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania. Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consu Read MoreMavefund brings filings, fundamentals, valuation, price history and news for Avantor, Inc. into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Net sales was $1,692.3M (reported); EPS was $0.21 (reported).
What changed
- Net sales reported to $1,692.3M; EPS reported to $0.21.
- Capital return update: free cash flow $142.8M.
- Net sales of $1,692.3 million; increase of 0.5%; organic decline of 0.4%.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
AVTR Jan 2028 25.000 put (AVTR280121P00025000) interactive stock chart
Headline from Yahoo Finance Singapore: AVTR Jan 2028 25.000 put (AVTR280121P00025000) interactive stock chart.
AVTR270115C00013000 interactive stock chart | AVTR Jan 2027 13.000 call stock
Headline from Yahoo Finance Singapore: AVTR270115C00013000 interactive stock chart | AVTR Jan 2027 13.000 call stock.
Avantor, Inc. (AVTR) Stock Forecasts
Headline from Yahoo Finance: Avantor, Inc. (AVTR) Stock Forecasts.
Are Medical Stocks Lagging Avantor (AVTR) This Year?
Headline from Yahoo Finance: Are Medical Stocks Lagging Avantor (AVTR) This Year?
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.